Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Jyothis T. George
ResearcherPublications, citations & collaboration network
Jyothis T. George is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 241 works, 10,874 citations, an h-index of 51 and an i10-index of 105.
241
Works
10,874
Citations
51
h-index
105
i10-index
How has Jyothis T. George's publication output changed over time?
ScholarIQpublication output · 2014–2020
Output grew0% over the shown period — from 1 works in 2014 to 1 in 2020.
1
3
3
3
1
20142017201820192020
What are the most-cited papers on Jyothis T. George?
ScholarIQmost cited works
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen, Mark E. Cooper, Steven E. Kahn, Nikolaus Marx, John H. Alexander, Michael Pencina, Robert D. Toto, Christoph Wanner, Bernard Zinman, Hans J. Woerle, David Baanstra, Egon Pfarr, Sven Schnaidt, Thomas Meinicke, Jyothis T. George, Maximilian von Eynatten, Darren K. McGuire, for the CARMELINA Investigators
JAMA. 20181,089 CitationsOPEN ACCESS
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
Silvio E. Inzucchi, Bernard Zinman, David Fitchett, Christoph Wanner, Ele Ferrannini, Martin Schumacher, Claudia Schmoor, Kristin Ohneberg, Odd Erik Johansen, Jyothis T. George, Stefan Hantel, Erich Bluhmki, John M. Lachin
Diabetes Care. 2017752 Citations
Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes
Julio Rosenstock, Steven E. Kahn, Odd Erik Johansen, Bernard Zinman, Mark A. Espeland, Hans J. Woerle, Egon Pfarr, Annett Keller, Michaela Mattheus, David Baanstra, Thomas Meinicke, Jyothis T. George, Maximilian von Eynatten, Darren K. McGuire, Nikolaus Marx, for the CAROLINA Investigators
JAMA. 2019612 CitationsOPEN ACCESS
The kisspeptin-GnRH pathway in human reproductive health and disease
Karolina Skorupskaite, Jyothis T. George, Richard A. Anderson
S19450991. 2014495 CitationsOPEN ACCESS
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
Christoph Wanner, John M. Lachin, Silvio E. Inzucchi, David Fitchett, Michaela Mattheus, Jyothis T. George, Hans J. Woerle, Uli C. Broedl, Maximilian von Eynatten, Bernard Zinman
Circulation. 2017472 CitationsOPEN ACCESS
Related on ScholarIQ
Parkinson's UK
Institution
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
Paper
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
Paper
Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes
Paper
The kisspeptin-GnRH pathway in human reproductive health and disease
Paper
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
Paper